"AI is not the biggest winner! Biotechnology has become a 'dark horse' in the US stock IPO market with an average return rate of 55%, significantly outperforming the overall market."

According to the Wise Financial APP, the biggest winner in the US IPO market this year is not an artificial intelligence (AI) company, but the biotechnology sector. Driven by improved industry fundamentals, active M&A activities by large pharmaceutical companies, and continuous capital inflows, biotech IPOs have outperformed the overall market significantly and attracted more and more companies to accelerate their listing pace during the summer window.